Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Risk model could help predict VTE in acute leukemia

Key clinical point: A new model for patients with acute leukemia appears to predict the risk of venous thromboembolism.

Major finding: The overall cumulative incidence of venous thromboembolism in the high-risk group was 44.0%, compared with 10.5% in the low-risk group.

Study details: A retrospective study involving 501 patients with acute lymphoblastic leukemia and acute myeloid leukemia.

Disclosures: The study was funded by the Canadian Institutes of Health Research. Dr. Lazo-Langner is an investigator with the Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR) Network.

Citation:

Lazo-Langner A et al. EHA Congress, Abstract S1642.